Fundraising FoxCaixa Capital Risc — Full Portfolio
10 tracked investments · listed companies and verified rows first
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)inCarole Guillonneau(Co-founder & Head of Research)inFrançois-Xavier Hubert(Co-founder, Past President & Board Member)
Co-investorsCriteria Bio VenturesNewton BiocapitalSound BioventuresSambrinvestWallonie Entreprendre
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs.
AI & Machine LearningBiotechMedical Devices
Beatriz Llamusí(Chief Scientific Officer & Co-Founder)in
Co-investorsHadean VenturesSound BioventuresBpifranceColumbus Venture PartnersAdBio partnersInvivo Capital Partners
flowww is management software for clinics and centers in the beauty, aesthetic medicine, health, and wellness sectors, offering digital medical records with e-signatures, appointment booking, stock traceability, automated marketing, and real-time analytics.
Digital HealthSaaSWellness & Fitness
Co-investorsSwanlaab Venture Factory
Glovo is an on-demand delivery app that lets users order food from restaurants as well as groceries and goods from supermarkets, shops, pharmacies, and florists in their city.
FoodTechLogistics & Supply ChainMarketplacesBarcelona, ES
Oscar Pierre(Founder)Sacha Michaud(Founder)
Co-investorsBlue LionBlue Lion GlobalBonsai Partners SGEIC, SACriteria Venture TechDirlangoEntrée Capital+11 more
Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
BiotechDeep TechHealthtechMedical DevicesMataró, ES
Marc Martinell(Co-Founder & Chief Executive Officer)in
Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture Fund+7 more
NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.
BiotechHealthtechLongevity
Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in
BoardJonathan Savidge(Independent Non Executive Chair)
Co-investorsBrandon CapitalCriteria Bio VenturesNovartis Venture FundSV Health InvestorsBritish Business BankBrandon Capital Partners+4 more
Tolerance Bio develops therapeutics targeting the thymus—the regulator of immune tolerance—to preserve, restore, and manipulate its function and extend health span.
BiotechDeep TechLongevityPhiladelphia, US
Francisco Leon(Executive Officer, Director)inPhilip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)in
BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)
Co-investorsBioAdvanceColumbus Venture PartnersCriteria Bio VenturesBen Franklin Technology Partners
Wallapop is a mobile marketplace app that enables users to buy and sell items with other nearby users in their local community.
ConsumerMarketplaces
Agustín Gómez(Founder)inAgustin Gomez(Founder)Gerard Olivé(Founder)Miguel Vicente(Founder)Rob Cassedy (CEO)(Founder)
Co-investorsAccelBonsai Partners SGEIC, SACometaCriteria Venture TechFJ LabsGarapa+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adaptam TherapeuticsCornerJob
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.